Ibudilast inhibits chemokine expression in rheumatoid synovial fibroblasts and exhibits immunomodulatory activity in experimental arthritis
<br/><strong>Objective: </strong>Ibudilast is a well‐tolerated, orally available type 4 phosphodiesterase (PDE4) inhibitor used to treat asthma and stroke. As PDE4 inhibition suppresses inflammatory mediator production and cell proliferation in leukocytes, ibudilast may be a valuab...
Главные авторы: | Clanchy, F, Williams, R |
---|---|
Формат: | Journal article |
Опубликовано: |
Wiley
2018
|
Схожие документы
-
Regulation of cytokine and chemokine expression by histone lysine methyltransferase MLL1 in rheumatoid arthritis synovial fibroblasts
по: Keita Okamoto, и др.
Опубликовано: (2024-05-01) -
Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
по: Jenney, Anne P, и др.
Опубликовано: (2018) -
Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
по: Haruka Tsuchiya, и др.
Опубликовано: (2021-03-01) -
Hyaluronan Inhibits Tlr-4-Dependent RANKL Expression in Human Rheumatoid Arthritis Synovial Fibroblasts.
по: Tatsuo Watanabe, и др.
Опубликовано: (2016-01-01) -
LEVELS OF ANGIOGENESIS-REGULATORY CHEMOKINES IN THE SYNOVIAL FLUID OF PATIENTS WITH RHEUMATOID ARTHRITIS
по: D. A. Zhebrun, и др.
Опубликовано: (2015-03-01)